-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Archive of Our Own Restores Service After Weeks-Long Security Shutdown
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Fire Erupts Near MetLife Stadium After Jets-Bills Game
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Met Office Issues Yellow Snow Warning for Nottinghamshire on Tuesday
-
UK Defence Secretary Warns Russia Nukes Not for Negotiation as HMS Vengeance Returns
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
NWPG's NFI Empire Reports Third Quarter 2026 Results
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
Covid-flu joint booster jab possible late 2023: Moderna
Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot.
The single vaccine for Covid-19, influenza and respiratory syncytial virus -- a common virus that causes the cold, but can be more serious for infants and elderly people -- could appear on the market before 2024.
"Best-case scenario will be the fall of '23," Moderna chief executive Stephane Bancel told a virtual World Economic Forum roundtable session.
"I don't think it would happen in every country, but we believe it's possible to happen in some countries next year.
"Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don't want to get two to three shots a winter, but to get one dose."
- Trials in progress -
Bancel said the RSV programme was in Phase III trials -- the final stage of human testing -- while the flu programme should be entering Phase III in the second quarter of this year.
Moderna's experimental flu shot, targeting four major strains, is based on the same mRNA method used in its Covid-19 jabs.
The technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells.
While Moderna's Covid-19 vaccine was based on the original strain of the virus, it was working on finishing an Omicron-specific jab within weeks, ahead of trials, said Bancel.
"We're hoping in the March timeframe we should be able to have data to share with regulators to figure out the next step forward."
- Hunt for 'holy grail' -
Beyond a vaccine specific to Omicron -- which is rapidly becoming the world's dominant strain -- laboratories are also pursuing a vaccine that works against all current and future Covid-19 mutations.
"There's some private sector partners that are pursuing it," said Richard Hatchett, chief executive of the Coalition for Epidemic Preparedness Innovations, which funds vaccine research and development.
"That would be the holy grail because we really don't want to be in position where we're chasing the new variants that are going to come.
"We don't want to be in a position where we're having to vaccinate everybody in the world every three or six months, or even annually, ideally."
Top US pandemic advisor Anthony Fauci added: "We really don't want to get into the whack-a-mole approach towards every new variant... because you'd be chasing it forever."
Bancel meanwhile said that Moderna had shipped 807 million doses of Covid-19 vaccine in 2021, of which a quarter went to middle- and low-income countries.
Thanks to extra capacity coming on stream before the end of March, the company hopes to be able to make two to three billion doses this year.
P.Stevenson--AMWN